A multi-stakeholder multicriteria decision analysis for the reimbursement of orphan drugs (FinMHU-MCDA study)

BACKGROUND: Patient access to orphan medicinal products (OMPs) is limited and varies between countries, reimbursement decisions on OMPs are complex, and there is a need for more transparent processes to know which criteria should be considered to inform these decisions. This study aimed to determine...

Descripción completa

Detalles Bibliográficos
Autores principales: de Andrés-Nogales, Fernando, Cruz, Encarnación, Calleja, Miguel Ángel, Delgado, Olga, Gorgas, Maria Queralt, Espín, Jaime, Mestre-Ferrándiz, Jorge, Palau, Francesc, Ancochea, Alba, Arce, Rosabel, Domínguez-Hernández, Raquel, Casado, Miguel Ángel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073956/
https://www.ncbi.nlm.nih.gov/pubmed/33902672
http://dx.doi.org/10.1186/s13023-021-01809-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8073956/
https://www.ncbi.nlm.nih.gov/pubmed/33902672
http://dx.doi.org/10.1186/s13023-021-01809-1

Ejemplares similares